Use Of Hif Alpha Stabilizers For Enhancing Erythropoiesis

Patent No. EP1633333 (titled "Use Of Hif Alpha Stabilizers For Enhancing Erythropoiesis") was filed by Fibrogen, Inc. on Jun 4, 2004. The application was issued on Aug 20, 2014.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
AKEBIA THERAPEUTICSMay 20, 2015JONES DAY

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1633333

FIBROGEN, INC.
Application Number
EP04754383A
Filing Date
Jun 4, 2004
Status
Revoked
Jan 9, 2026
Publication Date
Aug 20, 2014